Guilherme Alfano
Close-Up
Email: galfano@closeupus.com
Email: support@close-upinternational.com
(Not applicable)
Guilherme Alfano
Close-Up
Email: galfano@closeupus.com
Email: support@close-upinternational.com
(Not applicable)
Guilherme Alfano
Close-Up
Email: galfano@closeupus.com
Email: support@close-upinternational.com
(Not applicable)
Seize the opportunity with our Fall Special and maximize your year-end budget!
Established in 2010, the National Registry of Rare Kidney Diseases (RaDaR) is an initiative by the UK Kidney Association. Its purpose is to gather longitudinal data on patients diagnosed with specific rare kidney diseases. With 33,000 patients enrolled from 109 sites throughout the UK, RaDaR stands as the largest rare kidney disease registry globally.
The Danish Multiple Sclerosis Registry is one of the oldest and largest MS registries globally, housing nationwide prospective data on all Danish residents diagnosed with MS from 1948 to the present. The registry undergoes a new build approximately every month, during which data are extracted, checked, and cleaned.
We are excited to announce the recent enhancements and upgrades in our tutorial - How to Create Collections on B.R.I.D.G.E. TO DATA®. This updated video demonstrates how to narrow down search results, save collections for future use, and leverage new features for even better profile comparisons.
Professor Danny Gale
Director
RaDaR Team
UNITED KINGDOM
Email: d.gale@ucl.ac.uk
Dr. Zoe Plummer
Senior Project Manager
RaDaR Team
UNITED KINGDOM
Email: zoe.plummer@ukkidney.org
1. Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, Steenkamp R, Wong K, Turner AN, Wang K, Gale DP, Barratt J. Long-Term Outcomes in IgA Nephropathy. Clin J Am Soc Nephrol. 2023 Jun 1;18(6):727-738.
2. Wong K, Pitcher D, Braddon F, Downward L, Steenkamp R, Masoud S, Annear N, Barratt J, Bingham C, Coward RJ, Chrysochou T. Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort. Kidney International Reports. 2024 May 9; 2067–2083.
3. Wong K, Pitcher D, Braddon F, Downward L, Steenkamp R, Annear N, Barratt J, Bingham C, Chrysochou C, Coward RJ, Game D, Griffin S, Hall M, Johnson S, Kanigicherla D, Karet Frankl F, Kavanagh D, Kerecuk L, Maher ER, Moochhala S, Pinney J, Sayer JA, Simms R, Sinha S, Srivastava S, Tam FWK, Turner AN, Walsh SB, Waters A, Wilson P, Wong E, Taylor CM, Nitsch D, Saleem M, Bockenhauer D, Bramham K, Gale DP; RaDaR consortium. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort. Lancet. 2024 Mar 30;403(10433):1279-1289.
4. Masoud S, Wong K, Downward L, Pitcher D, Webb NJ, Proudfoot C, RaDaR Consortium, Wong EK, Gale DP. Clinical Predictors of Long-term Outcomes in C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis within the UK RaDaR Registry. medRxiv. 2024:2024-02.
